Accelerating Biologics Discovery & Development Through Transformative Technologies & Overcoming Strategic Challenges
A concise report featuring insights from the prominent thought leaders of Biologics 2024
Exploring Innovative Approaches Throughout the CGT Development Journey
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Cell UK
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Antibody & Protein Engineering
Oxford Global's R&D Key 40 Stories 2022
Download a copy of the R&D Key 40 Stories 2022 eBook today.
NextGen Therapeutics
Gilead Pay Big Bucks for MacroGenics' Blood-Cancer Targeting Bispecific
Gilead announced a $1.7 billion licence-option deal for MacroGenics’ MGD024 bispecific once Phase I trials conclude.
Bioanalysis
Turbocharging Potency Assays – Challenges and Opportunities from Multispecific Drug Modalities
The development of multispecific drugs is an inherently complex and challenging process. Barbara Hebeis of AstraZeneca talks us through challenges surrounding the development of appropriate potency assays, and the opportunities the field offers.
Antibody & Protein Engineering
The STING in Immunotherapy’s Tail
Research from the University of North Carolina into STING agonists provides new insights for immunotherapy cancer treatments.
Antibody & Protein Engineering
Eisai’s Alzheimer's Drug Offers New Hope
Eisai’s new drug lecanemab has shown small but significant benefits for people with early Alzheimer’s disease.
Antibody & Protein Engineering
Is Your WASH Causing Inflammation? Protein Complex Linked to Inflammatory Conditions
Research published by the Scripps Research Institute reveals the WASH protein complex as a crucial factor in neutrophil-triggered inflammation.
Why We Develop Autoimmunity: Hyperstimulation of Genetically Prone Subjects
Professor Yehuda Shoenfeld explains his findings in establishing links between genetic predisposition and hyperstimulation of the immune system and how this may help us better understand the development of autoimmunity.
Advanced Vaccine Platforms & Technologies
Wieslaw Swietnicki, Head of Biosynthesis and Bioengineering Group at the Institute of Industrial Organic Chemistry, leads a discussion on the current outlook for advanced vaccine platforms, technologies, and development.
Pfizer’s Pneumococcal Vaccine Shows Great Promise in European Study
Pfizer’s new PCV candidate is set to become the most effective protector against pneumococcal infections for infants.
Peptide Chemistry
FDA Gives Green Light to Long-Awaited Botox Competitor
Competition between cosmetic treatments begins.
